By Sneha S K and Amina Niasse Feb 23 (Reuters) - Online telehealth company Hims & Hers Health, which sells weight-loss drugs, hormone replacement therapies and health services, on Monday forecast ...

Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.

Can you eat your way to glowing, younger-looking skin? If you believe the adverts for collagen gummies, pills and powders, then yes.

Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by ...

"Our average customer is closer to a Starbucks barista." The post It Seems Bad That Temu Is Selling Peptides appeared first ...

At $16, Hims & Hers Health stock is cheap on sales metrics, but upside is capped pending regulatory clarity and proof of profit pool rebuild. Read why HIMS is a Hold.

With insurance plans dropping coverage of the drugs, those of us benefiting from them face a costly decision — beyond just ...

But the doctors warned that if someone had coffee alongside yohimbine, a supplement that may boost feel-good hormones in the brain, or synephrine, a supplement popular with athletes that can boost ...

Bunnie Xo recalled spending $2 million on drugs, partying and men while she was working as an escort in her 20s, years before ...

Bunnie Xo—whose memoir Stripped Down: Unfiltered and Unapologetic is out now—exclusively shared with E! News that she and ...

Women with type 2 diabetes who started on metformin rather than a sulfonylurea had roughly 30 percent lower odds of dying before age 90, according to a new study built on decades of data from the ...